Major Depressive Disorder, Post Traumatic Stress Disorder
Conditions
Keywords
Anxiety disorders, Behavioral intervention, Psychology
Brief summary
The purpose of this study is to pilot a primary-care based mindfulness intervention for chronically traumatized African Americans screening positive for posttraumatic stress disorder (PTSD) and major depressive disorder (MDD) in primary care clinics within an urban public hospital. The study will utilize a randomized controlled trial (RCT) design along with a multi-method psychological and physiological assessment approach to establish the feasibility and acceptability of a mindfulness-based cognitive therapy (MBCT) intervention for primary care versus wait-list control in African Americans with chronic trauma exposure and comorbid PTSD and MDD. Preliminary mechanisms of action associated with MBCT including emotion dysregulation and autonomic function will be evaluated. The data collection and 8-session group intervention will take place in primary care clinics within an urban public hospital serving primarily low-income, minority individuals (\>80% African American).
Detailed description
There is significant public health burden of chronic trauma exposure in low income, predominantly ethnic minority, urban communities, which is reflected in the extraordinarily high levels of trauma-related psychiatric disorders, particularly PTSD and MDD. Despite this, limited access to behavioral health treatment and significant barriers to treatment engagement and success remain and integrating mind-body approaches in medical settings could be a critical next step in treating chronically traumatized individuals in these urban settings. This study will utilize a randomized controlled trial design along with a multi-method assessment approach to ascertain the feasibility, acceptability, and preliminary mechanisms of action and outcomes of mindfulness-based cognitive therapy versus wait-list control in 80 African Americans with chronic trauma exposure and comorbid PTSD and MDD symptoms. Participants will be randomized to an 8-session (90 minutes each) group intervention or wait-list control. The researchers will examine the retention and follow-up rates, participants' report of acceptability and interest in the intervention, and examine barriers to treatment engagement through self-report measures and exit interviews. This study will also investigate preliminary mechanisms of action and outcomes of the mindfulness intervention in targeting emotion regulation and autonomic processes by measuring self-report of emotion dysregulation using the Difficulties in Emotion Regulation Scale and autonomic arousal to trauma cues using eSense technology to assess skin conductance during administration of Standardized Trauma Interview. Latent growth modeling will assess relative changes in emotion dysregulation and autonomic function over time through intervention and 1 month follow-up.
Interventions
The intervention consists of MBCT for the prevention of depression relapse with adaptations for discussing trauma and PTSD. Participants attend eight, weekly 90-minute group sessions involving skills training and in-class practice. Participants will return one month after the intervention has ended for a follow-up assessment.
Sponsors
Study design
Masking description
Staff members conducting the Clinician Administered PTSD Scale and the Mini-International Neuropsychiatric Interview will be blind to study arm assignment.
Intervention model description
Participants will be randomized with block stratified randomization (in blocks of 20) to ensure variability in PTSD and MDD diagnosis in the two groups.
Eligibility
Inclusion criteria
* ability to provide informed consent * willingness to participate in study * self-identity as African American * history of childhood and/or adult trauma exposure (3 total criterion A traumas) * positive PTSD screen (PC-PTSD ≥ 3) * positive MDD screen (PHQ-9 ≥ 5)
Exclusion criteria
* presence of intellectual disability, bipolar, or psychotic disorder * presence of current substance use disorder (past 1 month) * active suicidality
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants Retained in Study | Baseline through Follow-up (1 month after the end of the 8-week intervention) | Retention rates were assessed using session attendance. Previous mindfulness-based stress reduction (MBSR) interventions among low-income minority populations have yielded completion rates of 53-80%. Based on 80% completion rates of MBSR in primary care and 75% completion rates of MBCT both in combat vet samples and the anticipated improved accessibility through primary care, it is expected that subjects in the intervention group will evidence at least 75% retention and follow-up rates. |
| Client Satisfaction Questionnaire (CSQ) Score | Week 8 (post-intervention assessment) | Feasibility and acceptability of the Mindfulness-Based Cognitive Therapy intervention was assessed using the Client Satisfaction Questionnaire (CSQ). The CSQ is an 8-item questionnaire asking respondents to rate the quality of care they received on a scale from 1 to 4 where 1 = poor and 4 = excellent. Total raw scores range from 8 to 32 where higher values indicate greater satisfaction. |
| Perceived Barriers to Psychological Treatment (PBPT) Scale Score | Week 8 (post-intervention assessment) | Barriers to treatment was assessed using the Perceived Barriers to Psychological Treatment (PBPT) scale. The PBPT is a 25-item scale asking respondents about factors that interfere with attending weekly therapy. Items are rated on a 5-point scale where 1 = impossible to attend and 5 = not a problem. Total raw scores range from 25 to 125 where higher scores indicate low barriers regarding attending psychotherapy. |
| Difficulties in Emotion Regulation Scale (DERS) Score | Baseline, Weeks 3, 5, 7, 8 (post-intervention assessment), and Follow-up (1 month after the end of the intervention) | The Difficulties in Emotion Regulation Scale (DERS) is a 36-item instrument assessing emotion dysregulation and includes six subscales (non-acceptance of emotions, difficulty with goal-directed behavior in the presence of negative emotions, difficulty controlling impulses in the presence of negative emotions, lack of awareness of emotions, limited use of effective emotion regulation strategies, and lack of understanding of emotions). Responses are scaled from 1 (almost never) to 5 (almost always). Total raw scores range from 36 to 180; certain items are reverse scored so that higher scores indicate increased difficulty with emotion regulation. |
| Number of Participants Reporting Change in Experience of Emotions or Handling Stressful Situations in Post-group Follow-up Questionnaire | Week 8 (post-intervention assessment) | Participants randomized to the MBCT intervention completed an open-ended, follow-up questionnaire designed to assess feelings and changes experienced from participation in the intervention. Participants were asked Have you noticed any changes in how you experience emotions or handle stressful situations?. Responses were given in text form rather than on a pre-set scale, and were then categorized as positive change, no change, or negative change. |
| Skin Conductance Among In-Person Intervention Participants | Baseline, Week 8 (post-intervention assessment) | Skin conductance (SC) response was measured among participants receiving the in-person intervention using a mobile SC device, eSense (Mindfield Biosystems). Continuous recording of SC is measured with electrodes on hands and data is transmitted through the eSense app. Using the PhenX Toolkit protocol, a two minute baseline measure of SC will be obtained and then SC levels were measured during administration of the Standardized Trauma Interview immediately following to determine physiological reactivity to trauma stimuli. SC response is calculated by subtracting SC level at the end of baseline recording (average of last 30 seconds) from the maximum SC level value during the trauma interview. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Five Facet Mindfulness Questionnaire Score | Baseline, Week 8 (post-intervention assessment), Follow-up (1 month after the end of the intervention) | The Five Facet Mindfulness Questionnaire is a 39-item instrument assessing mindfulness, and includes five facets (observing, describing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience). Participants respond to each item on a scale of 1 to 5 where 1 = the statement is never or very rarely true for them and 5 = the statement is very often or always true. Total raw scores range from 39 to 195; certain items are reverse scored so that higher scores indicate increased mindfulness. |
| Number of Participants With PTSD by Primary Care PTSD Screen (PC-PTSD) Determination | Baseline, Week 8 (post-intervention assessment), Follow-up (1 month after the end of the intervention) | The Primary Care PTSD Screen (PC-PTSD) is a 5-item screen designed for use in primary care used to assess for presence of PTSD symptoms and serve as PTSD screener. Respondents answer yes or no to each question and an individual is considered to have PTSD if they respond with yes to at least 3 of the 5 questions. |
| Self Compassion Scale, Short Form Score | Baseline, Week 8 (post-intervention assessment), Follow-up (1 month after the end of the intervention) | The Self Compassion Scale is a 12-item instrument assessing how respondents typically act towards themselves during difficult times. Items are answered on a scale of 1 to 5 where 1 = almost never and 5 = almost always. Total scores range from 12 to 60; certain items are reversed scored so that higher scores indicate increased self compassion. |
| Patient Health Questionnaire-9 (PHQ-9) Score | Baseline, Week 8 (post-intervention assessment), Follow-up (1 month after the end of the intervention) | The Patient Health Questionnaire-9 (PHQ-9) will assess for presence of depressive symptoms and serve as a major depressive disorder (MDD) screening tool. The PHQ-9 is a 9-item tool that asks respondents to indicate how frequently they have felt symptoms of depression on a scale of 0 to 3 where 0 = not at all and 3 = nearly every day. Total scores range from 0 to 27, where higher scores indicate worse depression. |
| PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 (PCL-5) Score | Baseline, Week 8 (post-intervention assessment) | The PCL-5 is a 20-item questionnaire asking respondents to report how much they have been bothered by problems in the past month on a scale of 0 (not at all) to 4 (extremely). Total scores range from 0 to 80 where higher scores indicate increased difficulty with responses to stressful experiences. |
| Beck Depression Inventory-II (BDI-II) Score | Baseline, Week 8 (post-intervention assessment) | The BDI-II is a 21-item instrument asking respondents to indicate how much they are bothered by negative feelings. Responses are on a scale of 0 to 3 where 0 = the problematic feeling is not present and 3 = the feeling is very strong. Total scores range from 0 to 63, where high scores indicate worse problems with negative feelings. |
| Number of Participants Diagnosed With PTSD Using the Clinician Administered PTSD Scale | Baseline, Week 8 (post-intervention assessment) | The Clinician Administered PTSD Scale is a semi-structured interview used for diagnosing PTSD. The number of participants diagnosed with PTSD pre- and post-intervention will be compared between study arms. |
| Mini International Neuropsychiatric Interview (MINI) MDD Determination | Baseline, Week 8 (post-intervention assessment) | The Mini International Neuropsychiatric Interview (MINI) is a semi-structured interview used for diagnosing MDD. The number of participants diagnosed with MDD pre- and post-intervention will be compared between study arms. |
Countries
United States
Participant flow
Recruitment details
Participants were recruited from Grady Health System in Atlanta, Georgia, USA. Participant enrollment began September 14, 2018 and the final study assessment occurred on August 18, 2023.
Pre-assignment details
Study enrollment was suspended in March 2020 due to the Coronavirus 2019 (COVID-19) pandemic. Enrollment reopened in September 2020 with a virtual intervention, rather than an in-person intervention.
Participants by arm
| Arm | Count |
|---|---|
| In-Person Mindfulness-Based Cognitive Therapy Participants randomized to receive Mindfulness-Based Cognitive Therapy (MBCT) for 8 weeks. Participants enrolled between September 2018 and March 2020 received at least some of the intervention in-person. | 18 |
| In-Person Wait-list Control Group Participants randomized to the wait-list control study arm were administered the study assessments while not receiving active treatment. Participants were given the opportunity to participate in the MBCT intervention following completion of the study assessments. Participants enrolled between September 2018 and March 2020 received at least some of the intervention in-person. | 16 |
| Virtual Mindfulness-Based Cognitive Therapy Participants randomized to receive Mindfulness-Based Cognitive Therapy (MBCT) for 8 weeks. Participants enrolled after recruitment re-opened in September 2020 received the intervention virtually. | 26 |
| Virtual Wait-list Control Group Participants randomized to the wait-list control study arm were administered the study assessments while not receiving active treatment. Participants were given the opportunity to participate in the MBCT intervention following completion of the study assessments. Participants enrolled after recruitment re-opened in September 2020 received the intervention virtually. | 20 |
| Total | 80 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Lost to Follow-up | 20 | 9 |
| Overall Study | Physician Decision | 1 | 1 |
| Overall Study | Withdrawal by Subject | 1 | 0 |
Baseline characteristics
| Characteristic | In-Person Mindfulness-Based Cognitive Therapy | Total | Virtual Wait-list Control Group | Virtual Mindfulness-Based Cognitive Therapy | In-Person Wait-list Control Group |
|---|---|---|---|---|---|
| Age, Continuous | 46.5 years STANDARD_DEVIATION 12.3 | 44.81 years STANDARD_DEVIATION 12.98 | 45.45 years STANDARD_DEVIATION 14.09 | 43.54 years STANDARD_DEVIATION 13.78 | 44.3 years STANDARD_DEVIATION 11.8 |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Black or African American | 18 Participants | 77 Participants | 19 Participants | 24 Participants | 16 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 3 Participants | 1 Participants | 2 Participants | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) White | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Region of Enrollment United States | 18 Participants | 80 Participants | 20 Participants | 26 Participants | 16 Participants |
| Sex: Female, Male Female | 14 Participants | 68 Participants | 19 Participants | 21 Participants | 14 Participants |
| Sex: Female, Male Male | 3 Participants | 11 Participants | 1 Participants | 5 Participants | 2 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 44 | 0 / 36 |
| other Total, other adverse events | 11 / 44 | 3 / 36 |
| serious Total, serious adverse events | 0 / 44 | 0 / 36 |
Outcome results
Client Satisfaction Questionnaire (CSQ) Score
Feasibility and acceptability of the Mindfulness-Based Cognitive Therapy intervention was assessed using the Client Satisfaction Questionnaire (CSQ). The CSQ is an 8-item questionnaire asking respondents to rate the quality of care they received on a scale from 1 to 4 where 1 = poor and 4 = excellent. Total raw scores range from 8 to 32 where higher values indicate greater satisfaction.
Time frame: Week 8 (post-intervention assessment)
Population: This analysis includes participants in the MBCT study arm who completed the Post-Intervention Assessment (25 participants) and who completed this questionnaire. Three participants had missing CSQ data due to an error where the questionnaire was not administered at this time-point.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Mindfulness-Based Cognitive Therapy | Client Satisfaction Questionnaire (CSQ) Score | 30.36 score on a scale | Standard Deviation 2.01 |
Difficulties in Emotion Regulation Scale (DERS) Score
The Difficulties in Emotion Regulation Scale (DERS) is a 36-item instrument assessing emotion dysregulation and includes six subscales (non-acceptance of emotions, difficulty with goal-directed behavior in the presence of negative emotions, difficulty controlling impulses in the presence of negative emotions, lack of awareness of emotions, limited use of effective emotion regulation strategies, and lack of understanding of emotions). Responses are scaled from 1 (almost never) to 5 (almost always). Total raw scores range from 36 to 180; certain items are reverse scored so that higher scores indicate increased difficulty with emotion regulation.
Time frame: Baseline, Weeks 3, 5, 7, 8 (post-intervention assessment), and Follow-up (1 month after the end of the intervention)
Population: One participant in MBCT requested all data removed so baseline score was unavailable; 1 participant in MBCT and 2 participants in Wait-list Control (WLC) had multiple missing self-report measures at baseline due to interviewer error. Missing data at Weeks 3, 5, and 7 were related to a participant not present at group or unable to be reached for the assessment component. The DERS was not administered to the WLC group at Weeks 3 and 7.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Mindfulness-Based Cognitive Therapy | Difficulties in Emotion Regulation Scale (DERS) Score | Baseline | 78.05 score on a scale | Standard Deviation 21.09 |
| Mindfulness-Based Cognitive Therapy | Difficulties in Emotion Regulation Scale (DERS) Score | Week 5 | 73.46 score on a scale | Standard Deviation 25.17 |
| Mindfulness-Based Cognitive Therapy | Difficulties in Emotion Regulation Scale (DERS) Score | Week 7 | 73.17 score on a scale | Standard Deviation 21.7 |
| Mindfulness-Based Cognitive Therapy | Difficulties in Emotion Regulation Scale (DERS) Score | Week 8 | 71.24 score on a scale | Standard Deviation 26.55 |
| Mindfulness-Based Cognitive Therapy | Difficulties in Emotion Regulation Scale (DERS) Score | Follow-up one month after end of intervention | 73.00 score on a scale | Standard Deviation 25.7 |
| Mindfulness-Based Cognitive Therapy | Difficulties in Emotion Regulation Scale (DERS) Score | Week 3 | 77.08 score on a scale | Standard Deviation 20.78 |
| Wait-list Control Group | Difficulties in Emotion Regulation Scale (DERS) Score | Baseline | 83.77 score on a scale | Standard Deviation 23.6 |
| Wait-list Control Group | Difficulties in Emotion Regulation Scale (DERS) Score | Week 8 | 73.55 score on a scale | Standard Deviation 24.36 |
| Wait-list Control Group | Difficulties in Emotion Regulation Scale (DERS) Score | Follow-up one month after end of intervention | 80.56 score on a scale | Standard Deviation 29.78 |
| Wait-list Control Group | Difficulties in Emotion Regulation Scale (DERS) Score | Week 5 | 83.03 score on a scale | Standard Deviation 25.71 |
Number of Participants Reporting Change in Experience of Emotions or Handling Stressful Situations in Post-group Follow-up Questionnaire
Participants randomized to the MBCT intervention completed an open-ended, follow-up questionnaire designed to assess feelings and changes experienced from participation in the intervention. Participants were asked Have you noticed any changes in how you experience emotions or handle stressful situations?. Responses were given in text form rather than on a pre-set scale, and were then categorized as positive change, no change, or negative change.
Time frame: Week 8 (post-intervention assessment)
Population: This analysis includes participants receiving the MBCT intervention, either in-person or virtually, who attended the post-intervention assessment and responded to this question.
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Mindfulness-Based Cognitive Therapy | Number of Participants Reporting Change in Experience of Emotions or Handling Stressful Situations in Post-group Follow-up Questionnaire | Positive change | 15 Participants |
| Mindfulness-Based Cognitive Therapy | Number of Participants Reporting Change in Experience of Emotions or Handling Stressful Situations in Post-group Follow-up Questionnaire | No change | 0 Participants |
| Mindfulness-Based Cognitive Therapy | Number of Participants Reporting Change in Experience of Emotions or Handling Stressful Situations in Post-group Follow-up Questionnaire | Negative change | 0 Participants |
| Wait-list Control Group | Number of Participants Reporting Change in Experience of Emotions or Handling Stressful Situations in Post-group Follow-up Questionnaire | Positive change | 11 Participants |
| Wait-list Control Group | Number of Participants Reporting Change in Experience of Emotions or Handling Stressful Situations in Post-group Follow-up Questionnaire | No change | 2 Participants |
| Wait-list Control Group | Number of Participants Reporting Change in Experience of Emotions or Handling Stressful Situations in Post-group Follow-up Questionnaire | Negative change | 0 Participants |
Number of Participants Retained in Study
Retention rates were assessed using session attendance. Previous mindfulness-based stress reduction (MBSR) interventions among low-income minority populations have yielded completion rates of 53-80%. Based on 80% completion rates of MBSR in primary care and 75% completion rates of MBCT both in combat vet samples and the anticipated improved accessibility through primary care, it is expected that subjects in the intervention group will evidence at least 75% retention and follow-up rates.
Time frame: Baseline through Follow-up (1 month after the end of the 8-week intervention)
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Mindfulness-Based Cognitive Therapy | Number of Participants Retained in Study | 22 Participants |
| Wait-list Control Group | Number of Participants Retained in Study | 26 Participants |
Perceived Barriers to Psychological Treatment (PBPT) Scale Score
Barriers to treatment was assessed using the Perceived Barriers to Psychological Treatment (PBPT) scale. The PBPT is a 25-item scale asking respondents about factors that interfere with attending weekly therapy. Items are rated on a 5-point scale where 1 = impossible to attend and 5 = not a problem. Total raw scores range from 25 to 125 where higher scores indicate low barriers regarding attending psychotherapy.
Time frame: Week 8 (post-intervention assessment)
Population: This analysis includes participants who completed the post-intervention assessment. Two participants in the Wait-list Control Group do not have data for the PBPT due to an error in not administering the instrument.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Mindfulness-Based Cognitive Therapy | Perceived Barriers to Psychological Treatment (PBPT) Scale Score | 48.23 score on a scale | Standard Deviation 15.6 |
| Wait-list Control Group | Perceived Barriers to Psychological Treatment (PBPT) Scale Score | 53.70 score on a scale | Standard Deviation 18.04 |
Skin Conductance Among In-Person Intervention Participants
Skin conductance (SC) response was measured among participants receiving the in-person intervention using a mobile SC device, eSense (Mindfield Biosystems). Continuous recording of SC is measured with electrodes on hands and data is transmitted through the eSense app. Using the PhenX Toolkit protocol, a two minute baseline measure of SC will be obtained and then SC levels were measured during administration of the Standardized Trauma Interview immediately following to determine physiological reactivity to trauma stimuli. SC response is calculated by subtracting SC level at the end of baseline recording (average of last 30 seconds) from the maximum SC level value during the trauma interview.
Time frame: Baseline, Week 8 (post-intervention assessment)
Population: 8 MBCT and 8 WLC participants do not have usable baseline data due to a missing measurement, noise/error in output, iPad malfunction, or request for data removal. 2 MBCT participants and 7 WLC participants do not have Week 8 data because it was unusable due to noise/error in output. 3 MBCT participants and 1 WLC participants missed SC data collection at Week 8 due to onset of the COVID-19 pandemic and 2 WLC participants were missing SC data collection at Week 8 due to iPad malfunction.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Mindfulness-Based Cognitive Therapy | Skin Conductance Among In-Person Intervention Participants | Baseline | 1.39 µSiemens (µS) | Standard Deviation 1.6 |
| Mindfulness-Based Cognitive Therapy | Skin Conductance Among In-Person Intervention Participants | Week 8 | 1.07 µSiemens (µS) | Standard Deviation 1.22 |
| Wait-list Control Group | Skin Conductance Among In-Person Intervention Participants | Baseline | 1.29 µSiemens (µS) | Standard Deviation 1.77 |
| Wait-list Control Group | Skin Conductance Among In-Person Intervention Participants | Week 8 | 0.62 µSiemens (µS) | Standard Deviation 0.64 |
Beck Depression Inventory-II (BDI-II) Score
The BDI-II is a 21-item instrument asking respondents to indicate how much they are bothered by negative feelings. Responses are on a scale of 0 to 3 where 0 = the problematic feeling is not present and 3 = the feeling is very strong. Total scores range from 0 to 63, where high scores indicate worse problems with negative feelings.
Time frame: Baseline, Week 8 (post-intervention assessment)
Population: 1 participant in the MBCT condition requested all data removed so baseline score was unavailable. Baseline data for 3 MBCT participants were also missing due to interviewer error. Additional missing data at Week 8 were due to interviewer error in not asking all the self-report questions or if a participant ran out of time and ended the assessment early and was unable to be reached at a later time to finish the assessment battery.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Mindfulness-Based Cognitive Therapy | Beck Depression Inventory-II (BDI-II) Score | Baseline | 33.80 score on a scale | Standard Deviation 11.13 |
| Mindfulness-Based Cognitive Therapy | Beck Depression Inventory-II (BDI-II) Score | Week 8 | 24.94 score on a scale | Standard Deviation 14.25 |
| Wait-list Control Group | Beck Depression Inventory-II (BDI-II) Score | Baseline | 36.39 score on a scale | Standard Deviation 10.42 |
| Wait-list Control Group | Beck Depression Inventory-II (BDI-II) Score | Week 8 | 25.16 score on a scale | Standard Deviation 13.81 |
Five Facet Mindfulness Questionnaire Score
The Five Facet Mindfulness Questionnaire is a 39-item instrument assessing mindfulness, and includes five facets (observing, describing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience). Participants respond to each item on a scale of 1 to 5 where 1 = the statement is never or very rarely true for them and 5 = the statement is very often or always true. Total raw scores range from 39 to 195; certain items are reverse scored so that higher scores indicate increased mindfulness.
Time frame: Baseline, Week 8 (post-intervention assessment), Follow-up (1 month after the end of the intervention)
Population: 1 participant in the MBCT condition requested all data removed so baseline score was unavailable. Additional missing data at Baseline, and Week 8 were due to interviewer error in not asking all the self-report questions or if a participant ran out of time and ended the assessment early and was unable to be reached at a later time to finish the assessment battery.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Mindfulness-Based Cognitive Therapy | Five Facet Mindfulness Questionnaire Score | Baseline | 119.81 score on a scale | Standard Deviation 19.82 |
| Mindfulness-Based Cognitive Therapy | Five Facet Mindfulness Questionnaire Score | Week 8 | 124.35 score on a scale | Standard Deviation 30.68 |
| Mindfulness-Based Cognitive Therapy | Five Facet Mindfulness Questionnaire Score | Follow-up | 130.14 score on a scale | Standard Deviation 24.13 |
| Wait-list Control Group | Five Facet Mindfulness Questionnaire Score | Baseline | 122.39 score on a scale | Standard Deviation 21.4 |
| Wait-list Control Group | Five Facet Mindfulness Questionnaire Score | Week 8 | 122.46 score on a scale | Standard Deviation 22.16 |
| Wait-list Control Group | Five Facet Mindfulness Questionnaire Score | Follow-up | 121.15 score on a scale | Standard Deviation 24.21 |
Mini International Neuropsychiatric Interview (MINI) MDD Determination
The Mini International Neuropsychiatric Interview (MINI) is a semi-structured interview used for diagnosing MDD. The number of participants diagnosed with MDD pre- and post-intervention will be compared between study arms.
Time frame: Baseline, Week 8 (post-intervention assessment)
Population: 1 participant in the MBCT condition requested all data removed so baseline score was unavailable.
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Mindfulness-Based Cognitive Therapy | Mini International Neuropsychiatric Interview (MINI) MDD Determination | Baseline | 26 Participants |
| Mindfulness-Based Cognitive Therapy | Mini International Neuropsychiatric Interview (MINI) MDD Determination | Week 8 | 12 Participants |
| Wait-list Control Group | Mini International Neuropsychiatric Interview (MINI) MDD Determination | Baseline | 23 Participants |
| Wait-list Control Group | Mini International Neuropsychiatric Interview (MINI) MDD Determination | Week 8 | 16 Participants |
Number of Participants Diagnosed With PTSD Using the Clinician Administered PTSD Scale
The Clinician Administered PTSD Scale is a semi-structured interview used for diagnosing PTSD. The number of participants diagnosed with PTSD pre- and post-intervention will be compared between study arms.
Time frame: Baseline, Week 8 (post-intervention assessment)
Population: 1 participant in the MBCT condition requested all data removed so baseline score was unavailable.
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Mindfulness-Based Cognitive Therapy | Number of Participants Diagnosed With PTSD Using the Clinician Administered PTSD Scale | Baseline | 32 Participants |
| Mindfulness-Based Cognitive Therapy | Number of Participants Diagnosed With PTSD Using the Clinician Administered PTSD Scale | Week 8 | 9 Participants |
| Wait-list Control Group | Number of Participants Diagnosed With PTSD Using the Clinician Administered PTSD Scale | Baseline | 21 Participants |
| Wait-list Control Group | Number of Participants Diagnosed With PTSD Using the Clinician Administered PTSD Scale | Week 8 | 21 Participants |
Number of Participants With PTSD by Primary Care PTSD Screen (PC-PTSD) Determination
The Primary Care PTSD Screen (PC-PTSD) is a 5-item screen designed for use in primary care used to assess for presence of PTSD symptoms and serve as PTSD screener. Respondents answer yes or no to each question and an individual is considered to have PTSD if they respond with yes to at least 3 of the 5 questions.
Time frame: Baseline, Week 8 (post-intervention assessment), Follow-up (1 month after the end of the intervention)
Population: 1 participant in the MBCT condition requested all data removed so baseline score was unavailable. Additional missing data at Week 8 and Follow-up were due to interviewer error in not asking all the self-report questions or if a participant ran out of time and ended the assessment early and was unable to be reached at a later time to finish the assessment battery.
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Mindfulness-Based Cognitive Therapy | Number of Participants With PTSD by Primary Care PTSD Screen (PC-PTSD) Determination | Baseline | 43 Participants |
| Mindfulness-Based Cognitive Therapy | Number of Participants With PTSD by Primary Care PTSD Screen (PC-PTSD) Determination | Week 8 | 16 Participants |
| Mindfulness-Based Cognitive Therapy | Number of Participants With PTSD by Primary Care PTSD Screen (PC-PTSD) Determination | Follow-up | 10 Participants |
| Wait-list Control Group | Number of Participants With PTSD by Primary Care PTSD Screen (PC-PTSD) Determination | Baseline | 36 Participants |
| Wait-list Control Group | Number of Participants With PTSD by Primary Care PTSD Screen (PC-PTSD) Determination | Week 8 | 21 Participants |
| Wait-list Control Group | Number of Participants With PTSD by Primary Care PTSD Screen (PC-PTSD) Determination | Follow-up | 15 Participants |
Patient Health Questionnaire-9 (PHQ-9) Score
The Patient Health Questionnaire-9 (PHQ-9) will assess for presence of depressive symptoms and serve as a major depressive disorder (MDD) screening tool. The PHQ-9 is a 9-item tool that asks respondents to indicate how frequently they have felt symptoms of depression on a scale of 0 to 3 where 0 = not at all and 3 = nearly every day. Total scores range from 0 to 27, where higher scores indicate worse depression.
Time frame: Baseline, Week 8 (post-intervention assessment), Follow-up (1 month after the end of the intervention)
Population: 1 participant in the MBCT condition requested all data removed so baseline score was unavailable. Additional missing data at Week 8 and Follow-up were due to interviewer error in not asking all the self-report questions or if a participant ran out of time and ended the assessment early and was unable to be reached at a later time to finish the assessment battery.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Mindfulness-Based Cognitive Therapy | Patient Health Questionnaire-9 (PHQ-9) Score | Baseline | 17.35 score on a scale | Standard Deviation 4.71 |
| Mindfulness-Based Cognitive Therapy | Patient Health Questionnaire-9 (PHQ-9) Score | Week 8 | 13.30 score on a scale | Standard Deviation 8.09 |
| Mindfulness-Based Cognitive Therapy | Patient Health Questionnaire-9 (PHQ-9) Score | Follow-up | 12.47 score on a scale | Standard Deviation 6.95 |
| Wait-list Control Group | Patient Health Questionnaire-9 (PHQ-9) Score | Baseline | 18.67 score on a scale | Standard Deviation 4.06 |
| Wait-list Control Group | Patient Health Questionnaire-9 (PHQ-9) Score | Week 8 | 13.64 score on a scale | Standard Deviation 6.17 |
| Wait-list Control Group | Patient Health Questionnaire-9 (PHQ-9) Score | Follow-up | 14.22 score on a scale | Standard Deviation 6.03 |
PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 (PCL-5) Score
The PCL-5 is a 20-item questionnaire asking respondents to report how much they have been bothered by problems in the past month on a scale of 0 (not at all) to 4 (extremely). Total scores range from 0 to 80 where higher scores indicate increased difficulty with responses to stressful experiences.
Time frame: Baseline, Week 8 (post-intervention assessment)
Population: 1 participant in the MBCT condition requested all data removed so baseline score was unavailable. Baseline data for 1 MBCT participant and 1 WLC participant was missing due to interviewer error. Additional missing data at Week 8 and Follow-up were due to interviewer error in not asking all the self-report questions or if a participant ran out of time and ended the assessment early and was unable to be reached at a later time to finish the assessment battery.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Mindfulness-Based Cognitive Therapy | PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 (PCL-5) Score | Baseline | 49.12 score on a scale | Standard Deviation 14.07 |
| Mindfulness-Based Cognitive Therapy | PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 (PCL-5) Score | Week 8 | 34.91 score on a scale | Standard Deviation 20.17 |
| Wait-list Control Group | PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 (PCL-5) Score | Baseline | 54.86 score on a scale | Standard Deviation 11.73 |
| Wait-list Control Group | PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 (PCL-5) Score | Week 8 | 37.41 score on a scale | Standard Deviation 18.6 |
Self Compassion Scale, Short Form Score
The Self Compassion Scale is a 12-item instrument assessing how respondents typically act towards themselves during difficult times. Items are answered on a scale of 1 to 5 where 1 = almost never and 5 = almost always. Total scores range from 12 to 60; certain items are reversed scored so that higher scores indicate increased self compassion.
Time frame: Baseline, Week 8 (post-intervention assessment), Follow-up (1 month after the end of the intervention)
Population: 1 participant in the MBCT condition requested all data removed so baseline score was unavailable. Additional missing data at Baseline, Week 8 and Follow-up were due to interviewer error in not asking all the self-report questions or if a participant ran out of time and ended the assessment early and was unable to be reached at a later time to finish the assessment battery.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Mindfulness-Based Cognitive Therapy | Self Compassion Scale, Short Form Score | Baseline | 31.44 score on a scale | Standard Deviation 8.01 |
| Mindfulness-Based Cognitive Therapy | Self Compassion Scale, Short Form Score | Week 8 | 35.42 score on a scale | Standard Deviation 10.86 |
| Mindfulness-Based Cognitive Therapy | Self Compassion Scale, Short Form Score | Follow-up | 34.65 score on a scale | Standard Deviation 10.86 |
| Wait-list Control Group | Self Compassion Scale, Short Form Score | Baseline | 32.45 score on a scale | Standard Deviation 8.15 |
| Wait-list Control Group | Self Compassion Scale, Short Form Score | Week 8 | 33.68 score on a scale | Standard Deviation 12.59 |
| Wait-list Control Group | Self Compassion Scale, Short Form Score | Follow-up | 34.04 score on a scale | Standard Deviation 12.59 |